Literature DB >> 15271793

Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells.

Elena Tenedini1, Maria Elena Fagioli, Nicola Vianelli, Pier Luigi Tazzari, Francesca Ricci, Enrico Tagliafico, Paolo Ricci, Luigi Gugliotta, Giovanni Martinelli, Sante Tura, Michele Baccarani, Sergio Ferrari, Lucia Catani.   

Abstract

Gene expression profiles of bone marrow (BM) CD34-derived megakaryocytic cells (MKs) were compared in patients with essential thrombocythemia (ET) and healthy subjects using oligonucleotide microarray analysis to identify differentially expressed genes and disease-specific transcripts. We found that proapoptotic genes such as BAX, BNIP3, and BNIP3L were down-regulated in ET MKs together with genes that are components of the mitochondrial permeability transition pore complex, a system with a pivotal role in apoptosis. Conversely, antiapoptotic genes such as IGF1-R and CFLAR were up-regulated in the malignant cells, as was the SDF1 gene, which favors cell survival. On the basis of the array results, we characterized apoptosis of normal and ET MKs by time-course evaluation of annexin-V and sub-G1 peak DNA stainings of immature and mature MKs after culture in serum-free medium with an optimal thrombopoietin concentration, and annexin-V-positive MKs only, with decreasing thrombopoietin concentrations. ET MKs were more resistant to apoptosis than their normal counterparts. We conclude that imbalance between proliferation and apoptosis seems to be an important step in malignant ET megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271793     DOI: 10.1182/blood-2003-07-2597

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Platelet genomics and proteomics in human health and disease.

Authors:  Iain C Macaulay; Philippa Carr; Arief Gusnanto; Willem H Ouwehand; Des Fitzgerald; Nicholas A Watkins
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  Proteomic approaches to dissect platelet function: Half the story.

Authors:  Dmitri V Gnatenko; Peter L Perrotta; Wadie F Bahou
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

Review 3.  The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death.

Authors:  T R Burton; S B Gibson
Journal:  Cell Death Differ       Date:  2009-01-09       Impact factor: 15.828

Review 4.  Platelet mRNA: the meaning behind the message.

Authors:  Jesse W Rowley; Hansjörg Schwertz; Andrew S Weyrich
Journal:  Curr Opin Hematol       Date:  2012-09       Impact factor: 3.284

5.  Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2.

Authors:  Zhao Chen; Michael Hu; Ramesh A Shivdasani
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

6.  Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.

Authors:  Baobing Zhao; Yang Mei; Lan Cao; Jingxin Zhang; Ronen Sumagin; Jing Yang; Juehua Gao; Matthew J Schipma; Yanfeng Wang; Chelsea Thorsheim; Liang Zhao; Timothy Stalker; Brady Stein; Qiang Jeremy Wen; John D Crispino; Charles S Abrams; Peng Ji
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

7.  Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.

Authors:  Irene Lopez-Vilchez; Ulla Hedner; Carmen Altisent; Maribel Diaz-Ricart; Gines Escolar; Ana M Galan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 8.  Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Authors:  Marlene S Williams; Ethan J Weiss; Marc S Sabatine; Daniel I Simon; Wadie F Bahou; Lewis C Becker; Leslie V Parise; Harold L Dauerman; Patricia A French; Susan S Smyth; Richard C Becker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

9.  Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis.

Authors:  Stefan O Ciurea; Delwin Merchant; Nadim Mahmud; Takefumi Ishii; Yan Zhao; Wenyang Hu; Edward Bruno; Giovanni Barosi; Mingjiang Xu; Ronald Hoffman
Journal:  Blood       Date:  2007-05-01       Impact factor: 22.113

10.  Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.

Authors:  Edwin Chen; Philip A Beer; Anna L Godfrey; Christina A Ortmann; Juan Li; Ana P Costa-Pereira; Catherine E Ingle; Emmanouil T Dermitzakis; Peter J Campbell; Anthony R Green
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.